(Q37952587)

25 August 2017

title

Bipolar depression: an evidence-based approach (English)

1 reference

25 August 2017

1 reference

Claudia F Baldassano

1

1 reference

25 August 2017

Alexander Hosey

series ordinal

2

1 reference

25 August 2017

Jordan Coello

series ordinal

3

1 reference

25 August 2017

language of work or name

English

0 references

publication date

1 December 2011

1 reference

Current Psychiatry Reports

25 August 2017

published in

1 reference

25 August 2017

volume

13

1 reference

25 August 2017

issue

6

1 reference

25 August 2017

page(s)

483-487

1 reference

Functional impairment and disability across mood states in bipolar disorder

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0238-7

Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0238-7

A Double-Blind, Placebo-Controlled, Prophylaxis Study of Lamotrigine in Rapid-Cycling Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0238-7

The prevalent clinical spectrum of bipolar disorders: beyond DSM-IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0238-7

Bipolar depression: pharmacotherapy and related therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0238-7

Clinical studies on the use of lamotrigine in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0238-7

Effectiveness of adjunctive antidepressant treatment for bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0238-7

A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0238-7

A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0238-7

Antidepressants for bipolar depression: a systematic review of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0238-7

Lithium-carbonate treatment in depression and mania. A longitudinal double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0238-7

Lithium Response in Unipolar Versus Bipolar Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0238-7

Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0238-7

Suicide risk in bipolar disorder during treatment with lithium and divalproex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0238-7

Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0238-7

Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0238-7

Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0238-7

Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0238-7

A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0238-7

Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0238-7

Clinical potential of lurasidone in the management of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0238-7

A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0238-7

Clinical response to risperidone in relation to plasma drug concentrations in acutely exacerbated schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0238-7

Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0238-7

Continuation and maintenance ECT in treatment-resistant bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0238-7

Pramipexole for bipolar II depression: a placebo-controlled proof of concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0238-7

A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0238-7

Efficacy and Safety of Lamotrigine as Add-On Treatment to Lithium in Bipolar Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0238-7

A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group

21 January 2018

1 reference

12 December 2020

Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study

1 reference

12 December 2020

Excess mortality in bipolar and unipolar disorder in Sweden

1 reference

12 December 2020

Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study

1 reference

12 December 2020

Treatment of depression in bipolar disorder: new directions for research.

1 reference

12 December 2020

Mood-stabilizing pharmacological treatment in bipolar disorders and risk of suicide

1 reference

12 December 2020

Effectiveness and safety of long-term antidepressant treatment in bipolar disorder

1 reference

12 December 2020

Pramipexole in refractory bipolar depression

1 reference

12 December 2020

Long-term worsening of bipolar disorder related with frequency of antidepressant exposure

1 reference

12 December 2020

Anticonvulsants in bipolar disorder

1 reference

12 December 2020

Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial

1 reference

12 December 2020

Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence

1 reference

12 December 2020

10.1007/S11920-011-0238-7

Identifiers

DOI

1 reference

25 August 2017

1 reference